Back to top

ANI Pharmaceuticals reports ‘positive’ results from Phase 4 Synchronicity trial

ANI Pharmaceuticals (ANIP) announced positive topline data from its Phase 4, open-label, single-arm Synchronicity clinical trial of Fluocinolone Ac...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

ANI Pharmaceuticals, Inc. (ANIP)